Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sequential Combo Immuno and Target Therapy (SECOMBIT) Study (SECOMBIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02631447
Recruitment Status : Unknown
Verified June 2019 by Fondazione Melanoma Onlus.
Recruitment status was:  Active, not recruiting
First Posted : December 16, 2015
Last Update Posted : June 10, 2019
Sponsor:
Collaborator:
Clinical Research Technology S.r.l.
Information provided by (Responsible Party):
Fondazione Melanoma Onlus

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : April 2021
Estimated Study Completion Date : December 2021